# 858 Therapeutics funding: rounds and investors

> 858 Therapeutics has raised $50M across 1 round since 2024. Investors include New Enterprise Associates, Insight Partners and Versant Ventures.

Source: https://millionrounds.com/company/858-therapeutics (Millionrounds; every figure on the page links to its filing or article)

United States · [Series B startup](https://millionrounds.com/companies)

# Who invested in *858 Therapeutics*

One round we have observed, with the 5 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Follow 858 Therapeutics and see its new rounds in your feed. [Start following](https://millionrounds.com/login?join=1&why=follow&next=%2Fcompany%2F858-therapeutics)

Funding summary Updated 27 Oct 2026

**$50M** raised across 1 round since 2024, from 1 source

- **Latest round:** Series B, $50M Sept 2024
- **Investors:** 5

See who backed them

## The rounds

- **Sept 2024** Series B **$50M** [New Enterprise Associates](https://millionrounds.com/fund/new-enterprise-associates) [Insight Partners](https://millionrounds.com/fund/insight-venture-partners) [Versant Ventures](https://millionrounds.com/fund/versant-ventures) [Cormorant Asset Management](https://millionrounds.com/fund/cormorant-asset-management) [Alexandria Venture Investments](https://millionrounds.com/fund/alexandria-venture-investments) Source recorded SEC filing: $25M sold, first sale Jun 2024

## Founders and team

From 858 Therapeutics's own website: 2 on the team.

- **Kim Russell** Director of HR & Site Manager
- **Spandana Ande** Senior Clinical Trial Associate

## Everyone who backed them

[New Enterprise Associates](https://millionrounds.com/fund/new-enterprise-associates) VC firm **1** round

[Insight Partners](https://millionrounds.com/fund/insight-venture-partners) VC firm **1** round

[Versant Ventures](https://millionrounds.com/fund/versant-ventures) VC firm **1** round

[Cormorant Asset Management](https://millionrounds.com/fund/cormorant-asset-management) Private equity **1** round

[Alexandria Venture Investments](https://millionrounds.com/fund/alexandria-venture-investments) VC firm **1** round

Missing a round, or an investor who was in one? [Tell us](https://millionrounds.com/corrections?slug=858-therapeutics).

## Quick answers about 858 Therapeutics

### Who invested in 858 Therapeutics?

858 Therapeutics's investors include New Enterprise Associates, Insight Partners, Versant Ventures, Cormorant Asset Management and Alexandria Venture Investments.

### How much has 858 Therapeutics raised?

858 Therapeutics has raised $50M across 1 round since 2024.

### When did 858 Therapeutics last raise?

858 Therapeutics's most recent round was a Series B of $50M in Sept 2024.

### What was 858 Therapeutics's biggest round?

Its most recent round, $50M in Sept 2024, is also its largest on record.

### Who backed 858 Therapeutics first?

858 Therapeutics's first round on record, in Sept 2024, was backed by New Enterprise Associates, Insight Partners and Versant Ventures and 2 others.

### What stage is 858 Therapeutics at?

858 Therapeutics's latest named round is a Series B, in Sept 2024.

### Where is 858 Therapeutics based?

858 Therapeutics is based in the United States.

## Companies like 858 Therapeutics

In the same sector, and raised in the last eighteen months.

[**Star Therapeutics** $325M · Oct 2026](https://millionrounds.com/company/star-therapeutics)[**Promaxo** $106M · Oct 2026](https://millionrounds.com/company/promaxo)[**Prolific Machines** $105M · Oct 2026](https://millionrounds.com/company/prolific-machines)[**IMIO** $19M · Oct 2026](https://millionrounds.com/company/imio)[**Rejuvenate Bio** $13M · Oct 2026](https://millionrounds.com/company/rejuvenate-bio)[**Clinical Ink** $24M · Oct 2026](https://millionrounds.com/company/clinical-ink)

## Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.

Open the investor searchOr these rounds in the app
